| __timestamp | Teva Pharmaceutical Industries Limited | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 9216000000 | 60987000 |
| Thursday, January 1, 2015 | 8296000000 | 125542000 |
| Friday, January 1, 2016 | 10044000000 | 210460000 |
| Sunday, January 1, 2017 | 11560000000 | 275119000 |
| Monday, January 1, 2018 | 10558000000 | 409539000 |
| Tuesday, January 1, 2019 | 9351000000 | 547758000 |
| Wednesday, January 1, 2020 | 8933000000 | 736300000 |
| Friday, January 1, 2021 | 8284000000 | 904200000 |
| Saturday, January 1, 2022 | 7952000000 | 1080300000 |
| Sunday, January 1, 2023 | 8200000000 | 1262200000 |
| Monday, January 1, 2024 | 8480000000 | 1530500000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial. Over the past decade, Teva Pharmaceutical Industries Limited and Vertex Pharmaceuticals Incorporated have showcased contrasting expense trends. From 2014 to 2023, Teva's cost of revenue has seen a gradual decline, dropping approximately 14% from its peak in 2017. This reflects strategic cost management amidst market challenges. In contrast, Vertex Pharmaceuticals has experienced a remarkable growth trajectory, with its cost of revenue surging by over 1,900% during the same period. This increase aligns with Vertex's expanding market presence and investment in innovative therapies. The data highlights a pivotal shift in the pharmaceutical landscape, where established giants like Teva streamline operations, while emerging leaders like Vertex capitalize on growth opportunities. These insights offer a window into the strategic maneuvers shaping the future of healthcare.
Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Alkermes plc's Expenses
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Teva Pharmaceutical Industries Limited vs United Therapeutics Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs CRISPR Therapeutics AG
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Agios Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Supernus Pharmaceuticals, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Celldex Therapeutics, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Galapagos NV
Comparing Cost of Revenue Efficiency: Teva Pharmaceutical Industries Limited vs BioCryst Pharmaceuticals, Inc.
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and MiMedx Group, Inc.'s Expenses